Back to markets

Egyptian Exchange

Last update 31 Dec 2025

October Pharma For Pharmaceutical Industries SAE · OCPH.CA

Egypt · Health Care · Pharmaceuticals · EGP

Price history

204.99 -0.56%

October Pharma For Pharmaceutical Industries SAE is an Egypt-based pharmaceuticals business in the healthcare sector, listed on the Egyptian Exchange under ticker OCPH.CA. October Pharma For Pharmaceutical Industries SAE is an Egypt-based company engaged in the manufacturing of pharmaceutical preparations. October Pharma For Pharmaceutical Industries SAE produces different pharmaceutical dosage forms products, including solid (tablets, capsules), liquid (syrup, drops, solution & spray), and subcontract (toll out manufacturing) for soft gelatin capsules, ampoule & vial, cream & suppository and powder. Its investment profile is best assessed through product quality, regulatory compliance, distribution, pricing, and demand from Egypt’s healthcare market. Key analysis points include business model clarity, durability of revenue sources, cost control, cash conversion, leverage, shareholder structure, and the consistency of public disclosures over time.

Fundamentals

connect to view more

Sign in to unlock the full fundamentals history.

Sign in
Metric  (EGP, B) 2024 2023 2022 2021 2020
Revenue Total Revenue 1
↗

OCPH.CA:Key Stats:11

Page: — · Key Stats|Key Financials¹

Total Revenue: 1228033.2870 → Total Revenue

EBITDA 0
↗

OCPH.CA:Key Stats:11

Page: — · Key Stats|Key Financials¹

EBITDA: 350460.6480 → EBITDA

EBIT 0
↗

OCPH.CA:Key Stats:11

Page: — · Key Stats|Key Financials¹

EBIT: 320568.7870 → EBIT

Net income Net Income 0
↗

OCPH.CA:Key Stats:11

Page: — · Key Stats|Key Financials¹

Net Income: 151838.8500 → Net Income

Operating margin 26%
Net margin 12%